Key result
This document provides author instructions for the Research Journal of Pharmacy and Technology without clinical data.
Why the study?
Inpatients in cardiology units face high risks of drug-related adverse reactions and poor adherence, yet the supportive role of clinical pharmacists remains largely underscored.
Does clinical pharmacist intervention improve outcomes and reduce drug-related complications in inpatients managed in cardiology units?
Does clinical pharmacist intervention improve outcomes and reduce drug-related complications in inpatients managed in cardiology units?
Clinical pharmacists play an essential role in reducing drug-related complications and improving care delivery for cardiology inpatients.
No data on pharmacist interventions; leaves open whether such roles improve cardiology inpatient outcomes.
Inpatients managed in cardiology units have shown high risks of encouraging drug-related adverse reactions. This is coupled with the influx of diuretics and cardioprotective drug mechanism. The support played by a clinical pharmacist in this context remains largely underscored cored. They play an essential role in supporting the overall pharmacological care for patients through clinical conditions evaluations and assessments. Further, it has been established that poor adherence to drug regimens is among the key exacerbating factors for heart failure occurrence. The need for conducting patient education process is essential in drug adherence process. This elevates the roles of clinical pharmacist in the care delivery through drug use optimization process, minimization of occurrence of adverse drug events and activities in the transitional care process with a key focus on medical reconciliation approaches in the care practice. This study has focused on systematic reviews, Meta-analysis and randomized controlled studies focusing on the pharmacist intervention in improving outcomes of cardiology patients in the hospital care settings. The results have demonstrated that their role can no longer be underestimated and play an important role in the care delivery process and reducing the overall drug-related complications in the care process.
No takes yet. Share an insight, caveat, or question.
Alissa et al. (2021) studied this question. This document contains author instructions for the Research Journal of Pharmacy and Technology and does not report clinical trial results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: